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ABSTRACT 
Objective: Allicin is a potential type 2 antidiabetic. Sulfonylurea receptor 1 (SUR1), nikotinamida adina dinukleotida dehydrogenase (Complex 1) 
and peroxisome proliferator-activated receptors gamma (PPARγ) are known as important receptors responsible in insulin resistance This study 
aimed to determine the physicochemical properties, and the affinity of allicin on SUR1, Complex 1 and PPARγ receptors based on the binding energy 
and the type of interaction.  
Methods: The physicochemical properties of allicin were analyzed using ChemOffice, and the binding energy and type of interaction were analyzed 
using the docking method with Autodock Vina.  
Results: The results from the analysis showed allicin has log p (logarithmic partition) 1.35, massa relativity (mr) 162.26 g/mol, and the binding energy of 
allicin on SUR1, Complex 1 and PPARγ are respectively-4.0;-3.0; and-4.1 kcal/mol. The type of interaction between allicin and receptors is van der waals.  
Conclusion: Allicin has good permeability and has the potential to bind to SUR1, Complex 1 and PPARγ receptors contributing to the activity of 
allicin as antidiabetic. 
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Diabetes mellitus type 2 is a disease which is shown by a high blood 
glucose level (hyperglycemia) [1]. World health organization (WHO) 
reported that the death-rate trend caused diabetic tend to rise four 
times from 1980 to 2014. It has caused mortality and disability 
earlier in human life [2]. Same with WHO report, the disease-rate in 
Indonesia rises two times from 2007 to 2013. In fact, 90% of the 
morbidity rate is contributed by type-2 diabetes that is started and 
caused by lifestyle while the rest are contributed by type-1 diabetes 
that is caused by genetic [3]. Current medication used to treat the 
disease is limited by the considerable side effect [4]. Therefore, there 
is a necessary to find alternative medicine. Natural has potential 
agents for drug development, such as garlic [5].  
Previous research has proven that allicin found in garlic extract can 
lower blood glucose level and improve insulin secretion in type 2-
diabetic rats [5]. The mechanism of its action is predicted similarly 
to sulfonylurea drug due to sulfur and hydrogen atom in allicin. 
Moreover, allicin has a functional group, thiosulfonate, allowing 
interaction with the receptor-like sulfonylurea drug [1]. However, its 
mechanism and drug target site is still unclear. The target and 
mechanism of drug-receptor are an important field in drug 
development through chemical-structure modification in order to 
optimize drug effect [6]. 
Docking molecule is a computational research method used to analyze 
potential mechanism action of a drug agent to receptor based on the 
binding energy and type of interaction contributing to the affinity 
between drug and receptor. This method is a preliminary study that 
could show information about potential drug target that could be used 
to continue to in vitro or molecular research such as modification of 
drug chemical structure [7-9]. In this research, allicin was docked to 
three receptors, sulfonylurea receptor 1 (SUR1) that is responsible to 
increase insulin secretion, nikotinamida adina dinukleotida 
dehydrogenase (Complex 1) activating adenosine monophosphate-
activated protein kinase (AMP-K) that is responsible to increase 
oxidation of free fatty acids, the inhibitor glucose transporter type-4 
(GLUT-4) and peroxisome proliferator-activated receptor-gamma 
(PPARγ) that is responsible for transcription coding of substance 
activating AMP-K [10-12]. The affinity of drug-receptor was analyzed 
based on binding energy and type of interaction.  
MATERIALS AND METHODS 
Preparation of ligand 
Three-dimensional (3D) chemical structure of ligand, allicin, in 
minimal energy was obtained using a computer program ChemDraw 
15.0. The structure was stored in pdb format [13, 14]. 
Analysis of physicochemical properties 
Physicochemical properties of allicin such as molecular weight and 
log p were analyzed using ChemDraw 15.0 [13]. 
Preparation of receptors 
The 3D chemical structure of target receptor, SUR1 (pdb Id.2ff7) and 
PPARγ (pdb Id.3k8s) were obtained by downloading from data bank 
RCSB protein. Complex 1 receptor was downloaded from the 
national center for biotechnology information (NCBI) database and 
obtained by homology modeling of Swiss software model [15-17]. 
Molecular docking 
Detection of receptor active sites, docking, and analysis of amino 
acids of receptors bound to ligand were conducted using 
Autodock Vina (Version 1.1.2) with the help of Autodock tools 
(ADT) and discovery studio to analyze ligand-receptor binding 
interaction [7, 14]. 
Data analysis 
The analysis result of ligand physicochemical properties (log p, mr, 
H acceptor, and donor) was using ChemDraw 15.0 and interpreted 
based on the rule of five Lipinski to predict ligand absorption and 
permeability properties. Determination of amino acids involved in 
the interaction between receptor and drug, and the binding energy 
(kcal/mol) was obtained using Autodock Vina (version 1.1.2) [8, 9, 
18]. 
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RESULTS AND DISCUSSION 
 
Fig. 1: Allicin 2D structure obtained using ChemDraw 15.0 
 
The analysis result of ligand physicochemical properties (table 2) 
showed that allicin has a molecular weight that is less than 500, log p 
is less than 5, the number of H donors (group OH and NH) is 0, and 
the number of H acceptors (atomic O and N) is 1, and log p is less 
than 5. According to the rule of Five Lipinski, the number of H 
donors that has good permeability is less than 5, the number of H 
acceptors that has good permeability is less than 10 and the 
molecular weight of substance that can penetrate biological 
membranes is less than 500 g/mol and Log P (solubility in 
octanol/water) value that describes the ability of a compound to 
dissolve in liquid of biological membrane is less than 5. Based on the 
data above, it can be concluded that allicin meets the requirements 
rule of Five Lipinski, means that allicin can be absorbed and 
distributed in the body [19]. 
 
Table 1: Results determination of chemical compounds physical properties ligands 
Molecule name Log P Weight Moleculer (g/mol) 
Allicin 1.35 162.26 
Glibenclamide 3.53 494.004 
Metformin 0.15 129.164 
Pioglitazon 3.58 356.44 
 
 
Fig. 2: Molecular docking interaction with ligand amino acid residues; A) Interaction residue SUR1-Allicin, B) Interaction residue SUR1-
glibenclamide 
 
Table 2: Binding energy of ligand bond SUR1 obtained Autodock Vina 1.1.2 
Molecules names Binding energy score (kcal/mol) RMSD 
Allicin -4.0 0.000 
Glibenclamide -8.6 0.000 
 
Docking result shows that the affinity of allicin to the receptor is 
lower than positive control, glibenclamide affinity for receptor as 
shown in table 2. This lower affinity of allicin can be caused by the 
amount of amino acid residue in the active site of receptor bound 
to allicin that are less than amino acid residue in the active site of 
receptor bound to glibenclamide. In spite of that, the binding site 
of allicin is at the active site of receptor bound to positive control 
showed in fig. 2, so these can contribute the activity of allicin as 




Fig. 3: Molecular docking interaction with ligand amino acid residues; A) Interaction residue complex 1-Allicin, B) Interaction residue 
complex 1-metformin 
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Table 3: Binding energy of ligand bond complex 1 obtained autodock vina 1.1.2 
Molecules names Binding energy score (kcal/mol) RMSD  
Allicin -3.0 0.000 
Metformim -3.6 0.000 
 
Docking result of the allicin affinity to Complex 1 receptor is close to 
positive control binding energy, metformin to the receptor. It can be 
caused by the amount of amino acid residue in the active site of 
receptor bound to allicin and type of interaction involved that is 
close to metformin, showed in fig. 3. Therefore, these can contribute 
to the activity of allicin as potential antidiabetic [7, 20]. 
 
 
Fig. 4: Molecular docking interaction with ligand amino acid residues; A) Interaction residue PPARγ-Allicin, B) Interaction residue 
PPARγ–pioglitazon 
 
Table 4: Binding energy of ligand bond PPARγ obtained autodock vina 1.1.2 
Molecules names Binding energy score (kcal/mol) RMSD  
Allicin -4.1 0.000 
Pioglitazon -8.2 0.000 
 
Docking result shows that the affinity of allicin to the receptor is 
lower than positive control, pioglitazone affinity to PPARγ as shown 
in table 4. This lower affinity of allicin can be caused by the amount 
of amino acid residues in the active site that are less than amino acid 
residue in the active site of receptor bound to pioglitazone. In spite 
of that, the binding site of receptor bound to allicin is at the active 
site of receptor bound to positive control showed fig. 4, so these can 
contribute the activity of allicin as potential antidiabetic, but it is not 
as high as a positive control [7, 20]. 
The active site of the receptor used to bind to allicin is set same with 
the positive control active site. It is conducted by setting the same 
dimension for both ligands. The analytical method of allicin binding 
energy bound to SUR1, Complex 1 and PPARγ receptors had also 
been validated by RMSD score. The score shows that there is no 
significance difference between replicated analysis from many 
conformations. In other studies showed that there is a relationship 
between docking studies and in vitro studies of the isolated pyran 
ester from Tragia cannabina and Ocimum sanctum which can reduce 
significant glucose levels [21, 22]. Although the binding score and 
RMSD showed that allicin is able to bind to the receptor, it was based 
on the calculation of the theoretical approach [23]. We need to 
conduct a research experiment to obtain the information about the 
allicin activity as antidiabetic, especially related to the quantity of 
compound that has antidiabetes activity.  
CONCLUSION 
Based on the analysis of physicochemical properties show that 
allicin has good permeability, and the docking result show that 
allicin has the potential to bind to SUR1, Complex 1 and PPARγ 
receptors contributing to the activity of allicin as antidiabetic. 
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